In the preceding article (1) evidence was presented which would not support the conception of a specific etiological relationship between respiratory infections and rheumatic fever in children. The designation, " streptococcal " respiratory infection, based solely on bacteriological findings, was questioned.
During these observations as to the relation between respiratory infections and rheumatic fever, an opportunity presented itself for obtaining information as to the immunological response of children experiencing respiratory infection and rheumatic recurrences. The serological method described by Todd (2) in 1932 for titrating antistreptolysin in the blood serum, by which a diagnosis of preceding hemolytic streptococcal infection may be made, was utilized.
From limited observations of normal individuals, mainly adults and others suffering from miscellaneous and streptococcal infections, Todd (3) and Coburn and Pauli (4) considered the normal range of antistreptolysin in serum to be from 5 to 100 units, and values of 200 or more as significant of preceding streptococcal infections. They also observed the antistreptolysin content to be consistently high during rheumatic fever and considered this as immunological evidence that the hemolytic streptococcus initiates the rheumatic process.
Myers and Keefer (5) , however, obtained an average in normals of 200 units, with a somewhat higher average, 500 units, in rheumatic fever, but they did not attribute etiological significance to this finding.
Wilson, Wheeler and Leask (6) , in a preliminary report on the antistreptolysin content of the serum in children, found that this antibody apparently passes through the placenta, being present in new-born infants. An analysis of the average titres for various age groups indicated a definite age correlation, the lowest values being obtained in the age period between three months and three years. It is of interest that the values obtained from sixteen mothers was within the normal range reported by Todd (3), but was significantly lower than those obtained for children six to sixteen years of age by these observers. The possible significance of this difference will be considered later.
Early in our studies it was apparent that single determinations of antistreptolysin were of little value because of the wide normal range and frequent presence of elevated titres for prolonged periods of a year or more. It was, therefore, considered advisable to obtain serial specimens at regular frequent intervals during the entire period of the observations. By this procedure it was possible to correlate the clinical course with the bacteriological and immunological findings of a representative series of subjects.
SUBJECTS AND METHOD
Todd's method for determining antistreptolysin in the blood serum was followed. The test is based on the presence in the blood serum of an agent which is capable of combining with, and neutralizing, the hemolysin in filtrates of broth cultures of hemolytic streptococcus. Todd (2) The methods for the preparation of these reagents are given in detail in the appendix. By adding diminishing quantities of serum to tubes containing 2.5 units of streptolysin, allowing 15 minutes at 37°C. for neutralization to take place, then adding one unit of red blood cells to each tube and incubating for one hour, the smallest amount of serum that would completely inhibit hemolysis was determined. This was recorded as the titre of the serum.
Adequate data for analysis was obtained for eighty rheumatic subjects who were under close observation for a period of from twelve to eighteen months. From serial antistreptolysin determinations, the basal level was obtained for each child. The lowest titre during the period of observation, which was maintained in apparent health, was selected as the basal level. In the majority of instances, periods of two to six months free from symptoms of infection preceded this value. The rise of titre above the basal level or above the level maintained during apparent health before the occurrence of respiratory infection or rheumatic activity was calculated.
A respiratory infection was considered a " streptococcal " infection if hemolytic streptococci were present in the pharyngeal flora during the respiratory infection, in contra-distinction to respiratory infections unassociated with hemolytic streptococci in the flora of the throat. Respiratory infections were graded as mild or severe based on local and constitutional symptoms.
The following were considered as rheumatic recrudescences: joint pains, purpura, arthritis, nodules, chorea and carditis.
OBSERVATIONS
In view of the observed frequency of respiratory infection and the high seasonal carrier rate of hemolytic streptococci in the pharyngeal flora of these children, it was obviously impossible to obtain antistreptolysin determinations in children free from either during the entire period of the observations. In this study the basal values obtained for 80 rheumatic subjects during apparent health showed a range of from 25 to 715 units with an average of 135 units. This is somewhat lower than that observed in our preliminary study (6) . The opportunity for special selection of subjects and the longer period of observation probably accounts for this difference. The antistreptolysin titre remained remarkably constant at various levels during periods when the subjects were free from respiratory infection. It is possible that the high basal levels which were maintained by apparently healthy children may represent chronic unrecognized infection or some infection occurring previous to our observation, as it was obviously impossible to eliminate subjects who had had respiratory infection the previous year. It would seem reasonable to consider these observations on the antistreptolysin content of the serum as representative for inactive rheumatic children, six to sixteen years old, in apparent health, although possibly not comparable to normal values given for adults.
A comparison of the range of antistreptolysin titre, the average titre and the rise observed during apparent health and infection is of interest. There was no significant difference in the range of antistreptolysin titre observed in subjects during health and during respiratory and rheumatic infections. There was no appreciable difference in the average titre of antistreptolysin obtained for subjects during respiratory infections not associated with hemolytic streptococci and similar infections associated with hemolytic streptococci in the pharyngeal flora.
Following respiratory infections irrespective of the bacteriological findings, a rise in titre was consistently although not invariably observed. The average rise and the percentage showing rise in titre was slightly higher following respiratory infections not associated with hemolytic streptococci in the pharyngeal flora, than following similar infections thus associated. The contrary might have been expected. Greater increments and higher percentage of subjects exhibiting a rise in titre were observed following severe respiratory and " streptococcal " infections than mild ones. The degree of rise was not always directly related to the severity of the respiratory infection or to the bacteriological findings. There was consider- It is of passing interest that about 50 per cent of the subjects carrying hemolytic streptococci in the throat during apparent health exhibited a slight rise in antistreptolysin titre.
The low average antistreptolysin titres observed by us (in preliminary studies) in average normal infants and children under the age of five years and by Todd (3), Coburn and Pauli (4) in adults may be related to the relative infrequency of respiratory infections at these age levels compared with the observed high incidence of respiratory infections in children five to sixteen years of age.
Following respiratory infections, the antistreptolysin curve was characterized by a steplike elevation within one to three weeks of the onset, rising to a peak and falling either by lysis within one to two months or remaining plateaulike at intermediate levels for longer periods, showing successive peaks following repeated respiratory infections.
The findings in rheumatic subjects during inactive periods and during respiratory infection must be considered in evaluating the significance of the antistreptolysin content of the serum during rheumatic activity.
Two-thirds of the subjects experiencing rheumatic recrudescences, unassociated with respiratory infections, did not show a rise of antistreptolysin titre. The average values obtained during rheumatic activity associated with respiratory infection and " streptococcal " respiratory infection were significantly elevated, but are comparable to values obtained in inactive rheumatic subjects during similar infections. The slightly higher average values, which obtained in the group of active rheumatic subjects who experienced severe "streptococcal" respiratory intfection, were influenced by the occurrence in five subjects of extremely high antistreptolysin values during intercurrent severe streptococcal infection (see protocol of Case 4, C. V.).
The rise and level of antistreptolysin in serum following respiratory infections seemed closely related to the extent of the constitutional and local symptoms associated with the respiratory infection, irrespective of the presence of hemolytic streptococci in the flora of the throat.
The antistreptolysin curves observed in subjects who developed respiratory infections either simul-taneously with, or during, rheumatic activity were similar to those described in subjects experiencing respiratory infections alone and bore no relation to the clinical course of rheumatic activity.
Antistreptolysin curves observed during rheumatic activity either maintained the same level noted before the onset of rheumatic activity or assumed the trend of curves observed during respiratory infections. A sharp rise of titre at the onset of rheumatic activity, unaccompanied by respiratory infection, which has been described by Coburn and Pauli, was not obtained. High titres during rheumatic activity were observed in subjects who experienced simultaneously rheumatic activity and respiratory infection. Other subjects maintained a high antistreptolysin level during rheumatic activity which had been present previously for a period of months. A rise of titre was frequently noted during the course of rheumatic activity, following intercurrent respiratory infection, indicating the ability of the subject to react to streptococcal infection. matic fever may be more clearly seen in the following protocols of representative cases. 
COMMENT
At the outset, it was arbitrarily assumed first, that respiratory infections associated with the presence of hemolytic streptococci in the flora of the throat were to be designated as " streptococcal " infections, and second, that a rise in the antistreptolysin titre of the serum was immunological evidence of a previous streptococcal infection. These criteria, we believe, are in accord with the statements of other observers in similar investigations.
The antistreptolysin content of the serum following such infections as scarlet fever, erysipelas and severe streptococcal respiratory infections associated with local and constitutional symptoms has been found to be significantly increased by all observers.
Of particular interest is the rise in titre in twothirds of subjects following upper respiratory infections unassociated with hemolytic streptococci in the pharyngeal flora. One must assume either that hemolytic streptococci were present although not found on examination of repeated throat cultures, or that the antistreptolysin content of the serum is not strictly type specific as Todd (3) believes, and that possibly partially hemolytic streptococci (alpha prime) predominant in the pharyngeal flora may play a role. Again, a rise in titre may be due to non-specific stimulation of this antibody during infection.
Irrespective of the significance of these findings, it is evident from our data that the antistreptolysin content of the serum during rheumatic activity appears to be related to the associated respiratory infection rather than to the rheumatic process. This view would seem to be supported by the low titres observed (in the necessarily limited number of observations) in subjects experiencing rheumatic activity unassociated with respiratory infection. It is also worthy of -I note that two-thirds of the total respiratory infections experienced by these 80 subjects were unassociated with rheumatic activity. Of the remaining third, two-thirds occurred either simultaneously with, or during, the rheumatic episode.
The wide normal range of antistreptolysin titre, the individual variation in response to streptococcal infection, the frequency of respiratory infections observed in these subjects, as well as the high carrier rate of hemolytic streptococci, make it difficult to evaluate their possible significance and relation to rheumatic fever. However, it would appear to be reasonable to state that our data do not indicate that the presence of hemolytic streptococci in the pharyngeal flora or that the presence in high titre of antistreptolysin in the serum is necessarily conclusive evidence of a streptococcal respiratory infection.
However, if we accept the criteria mentioned as bacteriological and immunological evidence of " streptococcal" respiratory infection, it is apparent from our observations that "streptococcal" respiratory infection did not, in the majority of cases, activate the rheumatic process and that a rise of antistreptolysin was not a constant accompaniment of rheumatic activity. Its presence appeared to be more frequently related to the coincidental occurrence of a respiratory infection.
Our observations being limited to children may not be entirely comparable to other investigations including adults. It may also be possible that the reaction to streptococcal infection in adults, like that to rheumatic fever, may be different from that in children. SUMMARY 1. There is presented a correlation of the clinical course with the bacteriological and immunological observations in 80 rheumatic subjects observed over a period of twelve to eighteen months.
2. The antistreptolysin titre for rheumatic subjects during apparent health gave a basal average of 135 units with a range of 25 to 715 units.
3. There was no significant difference in the range of antistreptolysin titre observed for subjects during apparent health and during respiratory and rheumatic infection.
4. A comparison of the antistreptolysin titres of inactive rheumatic subjects during respiratory and " streptococcal " respiratory infections showed a higher average titre and greater rise in titre for subjects experiencing respiratory infection unassociated with hemolytic streptococci in the pharyngeal flora.
5. Two-thirds of the subjects experiencing rheumatic activity unassociated with respiratory infections did not exhibit a rise in antistreptolysin titre.
6. The antistreptolysin titre of active rheumatic subjects experiencing respiratory and " streptococcal" respiratory infections was similar to that observed for inactive rheumtaic subjects experiencing these infections.
7. Following respiratory infections the antistreptolysin curve was characterized by a step-like elevation within one to three weeks of the onset, rising to a peak and falling by lysis within one or two months or remaining plateau-like at intermediate levels for longer periods, showing successive peaks following repeated respiratory infections.
8. The rise of the level of antistreptolysin in the serum following respiratory infections seemed directly related to the extent of the local and constitutional symptoms irrespective of the presence of hemolytic streptococci in the pharyngeal flora.
9. The antistreptolysin curves observed in subjects who developed respiratory infection simultaneously with, or during, rheumatic activity were similar to those described in subjects experiencing respiratory infections alone and bore no relation to the clinical course of rheumatic activity. It appears that the factors involved in lysin-antilysin reactions are analogous to those concerned in toxinantitoxin neutralization. In the latter instance no accurate standardization was possible until the neutralizing dose was replaced by the combining dose, and a standard serum of known antitoxin content was adopted.
Preparation of Reagents Rabbit red blood cells:
On the afternoon before the tests were to be made, blood was withdrawn from the rabbit's heart, placed in a sterile tube, defibrinated by stirring with wooden applicators and stored in refrigerator over night. Next morning the cells were washed six times with sterile 0.9 per cent sodium chloride solution. In the final washing they were centrifugalized 15 minutes at 1500 R.P.M.; they were then diluted to make a 5 per cent suspension.
Streptolysin filtrate:
The broth in which the streptococci were cultivated was prepared by a modification of the method described by Todd and Hewitt (8) . Fresh, finely minced beef hearts, trimmed free of fat, were used instead of horse flesh; these were received from the abattoir the same day the animals were killed. Two liters of distilled water were added to each kilo of meat in an enamelware kettle, the mixture was well stirred and placed in refrigerator over night. Fat particles, if present, were skimmed from the surface, and the mixture was heated slowly over a free flame until the temperature reached 80°C., where it was kept for 30 minutes. The contents of the kettle were stirred constantly during the heating process.
The fluid was then strained through coarse wire gauze, filtered through Prat-Dumas number 45 filter paper and collected in a tall glass cylinder. Part of the residual fluid was removed from the meat by gentle pressure. The temperature of the infusion after filtration was about 500 C. The following ingredients were added: proteosepeptone, " Difco," 20 grams per liter, sprinkled on surface and allowed to dissolve; dextrose, sodium chloride, and sodium bicarbonate, 2 grams of each per liter; dibasic sodium phosphate (12 H20), 1 gram per liter. When these were dissolved, reaction was adjusted to pH 8.0 with 10 per cent sodium hydroxide solution. Medium was well stirred and placed in refrigerator over night.
A heavy amorphous sediment had formed, leaving a fairly clear supernatant fluid which was removed with a siphon and filtered through Whatman number 12 filter paper. Medium was sterilized by filtration through a battery of six Chamberland F bougies, using a water vacuum pump. The finished product was collected, in 1500 cc. lots, in two-liter flasks closed with two-hole rubber stoppers provided with two right angle glass tubes. The tube to which the suction was applied was filled with non-absorbent cotton to prevent air contamination; the other was covered with a small test tube when not in use. When filtration was completed, flasks were placed in incubator for two days as a sterility test.
Each 1500 cc. lot was inoculated with 2.5 cc. of an 8-hour culture of hemolytic streptococcus 2 in 0.3 per cent dextrose hormone broth. The inoculation was made through the open tube in the stopper of the flask while gentle suction was being applied to the other tube. After 16 hours incubation flasks were placed in ice water to check growth and culture was filtered through six Chamberland F bougies. The first 300 cc. of filtrate were discarded because of the low streptolysin content (8); the remainder was collected in 1500 cc. lots by the same procedure that was used with the broth filtrate. The open tube in the stopper was sealed off in a Bunsen flame, the other tube was connected with a water pump, and strong suction was applied for 2% hours, the flasks being immersed in a water bath at 300 C. Bubbling was vigorous at first, but gradually diminished and finally ceased. Vacuum was released, 1.5 gram of sodium hydrosulphite (Baker) and 15 cc. of N/I sodium hydroxide were added to each 1500 cc., and suction was again applied for 30 minutes. The reduced filtrate was then distributed in 50 cc. Florence flasks, sealed with a 4 cm. layer of sterile vaseline containing 12 per cent paraffin, and stored in refrigerator.
After three weeks the reaction of this filtrate was pH 7.3; the minimum hemolytic dose was 0.05 cc. (kept at 00 C., this showed no change in ten months).
Antistreptalysin serum:
Patient's blood was withdrawn with a dry sterile needle and syringe, placed in a sterile tube and allowed to clot. Tube was centrifugalized, serum was removed with a pipette and transferred to another tube which was then closed with a sterile paraffined cork and stored in refrigerator. Before testing the serum the tubes were placed in a water bath at 550 C. for 15 minutes to inactivate any natural hemolysin that might be present.
Repeated determinations made with the same serum 2We used strain WPRL which we obtained through the kindness of Dr. Hodge of the Rockefeller Institute. This stock culture was kept in blood broth.
showed that the antistreptolysin titre remained practically constant for at least eight months.
Technique of test:
If the combining dose of the streptolysin filtrate was less than 0.2 cc., the filtrate was diluted with 0.9 per cent sodium chloride so that 2.5 units of streptolysin were contained in 0.5 cc. of the dilution. Preliminary test: The serum to be tested was inactivated for 15 minutes at 55°C. Four dilutions were made with 0.9 per cent sodium chloride, 1-10, 1-50, 1-100 
